Ordonnance du président du Tribunal du 20 juillet 2016. MSD Animal Health Innovation GmbH et Intervet international BV contre Agence européeDecision
… of an MA file for a veterinary medicinal product, the applicants’ claim that those texts — namely, inter alia, Articles 36, 37(3), 38(3), 57(1), point l, 57(2), 76 and 80 of Regulation No 726/2004 and Articles 13 and 76 of Directive …
20 Jul 2016 · 62015TO0729
Judgment of the General Court (Second Chamber, Extended Composition) of 5 February 2018. Pari Pharma GmbH v European Medicines Agency.Decision
Articles 11, 12, 36 and 37(3) of Regulation No 726/2004 also reflect the legislature’s intention that the MA procedure should be transparent, even where that procedure does not result in a decision or leads to a decision refusing MA. …
5 Feb 2018 · 62015TJ0235
Judgment of the General Court (Second Chamber) of 5 February 2018. PTC Therapeutics International Ltd v European Medicines Agency.Decision
Articles 11, 12, 36 and 37(3) of Regulation No 726/2004 also reflect the legislature’s intention that the MA procedure should be transparent, even where that procedure does not result in a decision or leads to a decision refusing MA. …
5 Feb 2018 · 62015TJ0718
Order of the Vice-President of the Court of 1 March 2017. European Medicines Agency (EMA) v MSD Animal Health Innovation GmbH and Intervet iDecision
The existence of such a presumption follows from the system established by the sector-specific legislation applicable to marketing authorisation for veterinary medicinal products, in particular by Article 36, Article 37(3), Article 38(3) …
1 Mar 2017 · 62016CO0512
Judgment of the General Court (Second Chamber) of 5 February 2018. MSD Animal Health Innovation GmbH and Intervet international BV v EuropeaDecision
Articles 11, 12, 36 and 37(3) of Regulation No 726/2004 also reflect the legislature’s intention that the MA procedure should be transparent, even where that procedure does not result in a decision or leads to a decision refusing MA. …
5 Feb 2018 · 62015TJ0729
Regulation (EU) 2019/5Lawamends
Regulation (EU) 2022/839Law
… 1, член 34, параграф 1, буква в), член 34, параграф 4, буква д) и член 37, параграф 1, втора алинея от Регламент (ЕО) № 726/2004 в редакцията му, …
Judgment of the General Court (Second Chamber) of 25 September 2018. Amicus Therapeutics UK Ltd and Amicus Therapeutics, Inc. v European MedDecision
Articles 11, 12, 36 and 37(3) of Regulation No 726/2004 also reflect the legislature’s intention that the marketing authorisation procedure should be transparent, even where that procedure does not result in a decision or leads to a …
25 Sep 2018 · 62017TJ0033
Opinion of Advocate General Hogan delivered on 11 September 2019. MSD Animal Health Innovation GmbH and Intervet International BV v EuropeanDecision
The wording of the first paragraph of Article 73 of Regulation 726/2004 is broad and unqualified. The fact that certain information has to be published proactively [See Article 35(6), Article 36, Article 37(3) and Article 38(2) and (3) of …
11 Sep 2019 · 62018CC0178